Drugs / L-Isoleucine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01208324 Comparator | Mar 2010 → Nov 2018 | premature menopause | University of Colorado, Denver | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-Isoleucine | “L-Isoleucine (4.2 g)” NCT01208324 ↗ |
| Route | Oral | “Each test day will involve the ingestion of 70 capsules.” NCT01208324 ↗ |